In a decision that could potentially save the NHS up to £500m a year, Mills & Reeve and Landmark Chambers yesterday secured a monumental Court of Appeal victory over Arnold & Porter and Covington & Burling, duly defeating two big pharma companies in the process. The contentious rematch saw both Bayer and Novartis fail to […]
Wachtell Lipton Rosen & Katz, De Brauw Blackstone Westbroek, Linklaters and Hengeler Mueller all picked up roles on the $11.5bn acquisition of a German pharmaceutical testing company by a US scientific instruments maker. Wachtell, Hengeler and Dutch firm NautaDutilh acted for Thermo Fisher, which yesterday bought the testing company Qiagen, advised by De Brauw, Linklaters […]
Taylor Wessing, Stephenson Harwood and Wiggin have negotiated a settlement for their clients GSK, Celon Pharma and Glenmark Pharma, just days before the dispute was meant to hit the courts. The claim was a multi-jurisdictional trademark and unfair competition claim brought by GSK in relation to duplications of an inhaler design. The inhaler was designed, […]
Richard Grimshaw appeared for the Claimant/Respondent in an appeal concerning the refusal by a district judge to grant relief from sanctions to the Defendant/Appellant in a moderately high value and complex clinical negligence case. The Defendant applied for an extension of time to serve a witness statement from a clinician after the deadline for exchanging […]
By Richard Grimshaw The Supreme Court will today start hearing the appeal in the case of XX v Whittington Hospital NHS Trust. The case concerns whether a claimant can recover the costs of surrogacy utilising different methods both within England and Wales but also utilising commercial surrogacy arrangements in California. Full details can be found […]
Clinical negligence experts from No5 Barristers’ Chambers have seen the successful conclusion of a claim involving Cauda Equina Syndrome with damages agreed at around £1.5million. Jonathan Jones QC and David Tyack, with Moosa Duke solicitors, represented the claimant, 37, who had a long history of back pain. The defendant NHS Trust was represented by Michael […]
Fieldfisher has lost a London partner to US firm Arnold & Porter, in a move that marks yet another blow to Fieldfisher’s IP and life sciences practice following a string of departures. Partner Beatriz San Martin has joined the US firm having spent over a decade at Fieldfisher. She joined in 2004 and ascended to […]
The Lawyer, in association with DLA Piper, recently hosted a roundtable focusing on the growing number of obstacles and opportunities faced by law firms and businesses alike when working with digital therapeutics Co-moderators Roger Wagland – Research and digital product director, The Lawyer Tom Heylen – partner, DLA Piper Gareth Stokes – partner, DLA Piper […]
Swiss pharmaceutical powerhouse Novartis is nearing the end of its global legal panel review, which is understood to have been launched earlier this year. The panel is underway following the appointment of GC Shannon Thyme Klinger, who took on the role in June 2018, replacing Felix Ehrat. Her appointment came four months after Novartis also […]
There are few industries that are on the brink of a technological revolution as life sciences and health care. The possibilities that AI, nano-implants and new wearable software present are still only imaginable in futuristic TV programmes. Nevertheless, the tech revolution is already happening, and even if it doesn’t fall under the radar for the […]
Kirkland & Ellis, Sullivan & Cromwell and Arnold & Porter Kaye Scholer are the firms involved in the latest deal between US pharmaceutical giants, Bristol-Myers Squibb, Celgene and Amgen, valued at $13.4bn. The deal is related to the $90bn merger between the Bristol-Myers Squibb and Celgene, announced in January, and the sale of Celgene’s skin […]
Peters & Peters and Sidley Austin have agreed to postpone the Servier trial in October as the parties await a decision in the Supreme Court and the European Court. The English Courts were due to decide in October whether the NHS failed to mitigate the losses it claims it suffered as a result of Servier’s […]